vimarsana.com

Latest Breaking News On - Cycle day - Page 8 : vimarsana.com

Taylor 3 Day Cycle – Polaris Trading Group

Topic: Taylor 3-Day Cycle Author: David D Dube’ (a.k.a. PTGDavid) Website: Polaris Trading Group Prior Session was Cycle Day 1 (CD1): As expected the CD1 decline unfolded, fulfilling Average Decline (3982), surpassing, and hitting lower Violation Levels. Prior range was 108 handles on 2.484M contracts exchanged. …Transition from Cycle Day 1 to Cycle Day 2

Taylor 3 Day Cycle – Polaris Trading Group

Topic: Taylor 3-Day Cycle Author: David D Dube’ (a.k.a. PTGDavid) Website: Polaris Trading Group Prior Session was Cycle Day 2 (CD2): Normal CD2 unfolded, as price consolidated recent activity forming a neutral balanced day. Prior range was 49 handles on 1.319M contracts exchanged. …Transition from Cycle Day 2 to Cycle Day 3 This leads us

Taylor 3 Day Cycle – Polaris Trading Group

Topic: Taylor 3-Day Cycle Author: David D Dube’ (a.k.a. PTGDavid) Website: Polaris Trading Group Prior Session was Cycle Day 3 (CD3): Markets continued to rally fulfilling 3 Day Cycle Target (4322) at which time price reversed direction, reverting back to the 4300 Strike Zone. Prior range was 49 handles (below the average of 64 )

Taylor 3 Day Cycle – Polaris Trading Group

Topic: Taylor 3-Day Cycle Author: David D Dube’ (a.k.a. PTGDavid) Website: Polaris Trading Group Prior Session was Cycle Day 1 (CD1): Normal CD1 unfolded as price declined to reach lower target levels outlined in previous DTS 8.9.22. Prior range was 42 handles (below average of 70 ) on 1.238M contracts exchanged. …Transition from Cycle Day

Taylor 3 Day Cycle – Polaris Trading Group

Topic: Taylor 3-Day Cycle Author: David D Dube’ (a.k.a. PTGDavid) Website: Polaris Trading Group Prior Session was Cycle Day 2 (CD2): This cycle day had early morning drama related to House Speaker Pelosi's visit to Taiwan. In the end, it was a "nothing-burger", but lots of sabre-rattling. Regarding trading, the end result was a normal

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.